Psilocybin: a revolution in psychedelic medicines in the US?

With many US states legalizing psilocybin for medical treatment, questions arise about whether this psychedelic drug, the most thoroughly researched of its kind, could transform how depression and other mental health conditions are treated. The article examines the potential for psilocybin to revolutionize psychiatric care as regulatory approval expands.

Study at a glance

Abstract

As a flurry of US states approve psilocybin for medicinal use, Joanne Silberner asks whether the most carefully studied of psychedelic drugs will revolutionise treatment of depression and other psychiatric ailments